ReviewChemical science2021
Disila- and digermabenzenes.
Review in Chemical science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reactions of isolable disilynes and digermynes with alkynes can result in the formation of the corresponding disila- (DSBs) and digermabenzenes (DGBs), wherein two carbon atoms of the benzene ring are replaced by silicon or germanium atoms. Detailed structural and spectroscopic analyses of these DSBs and DGBs have revealed that they exhibit considerable aromaticity, comparable to that of benzene. However, in contrast to the all-carbon system benzene, these DSBs and DGBs are highly reactive toward small molecules such as oxygen, hydrogen, 1,3-dienes, and water. During the investigation of their reactivity, we discovered that a 1,2-DGB works as a catalyst for the cyclotrimerization of arylalkynes, which provides access to the corresponding 1,2,4-triarylbenzenes. In this perspective article, our recent progress in the area of DSB and DGB chemistry is summarized.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.